New Hampshire Union Leader – Quotes Seddon Savage, adjunct associate professor of anesthesiology and a member of the New Hampshire Governor’s Commission on Alcohol and Drug Abuse Prevention, Treatment and Recovery, about how doctors at specialty pain clinics usually concentrate on treatments and procedures, while nurse practitioners and physician assistants handle medications and prescriptions. “Prescribing opioids, particularly prescribing them well, is very time-consuming,” says Savage. “I think everyone needs more training.”
In the News
At the Hospitals: Director of PTSD Center Honored
Valley News – Paula Schnurr, research professor of psychiatry and executive director of the Department of Veterans Affairs’ National Center for Posttraumatic Stress Disorder, received the International Society for Traumatic Stress Studies Lifetime Achievement Award last month at the organization’s annual meeting in New Orleans, La.
How Your Yoga Class Might Actually Save You Money
Health – Quotes James Stahl, associate professor of medicine, about a recent study showing that mind-body interventions offer a way for patients to engage in their own treatment, thus reducing doctors visits and nipping problems in the bud.
Presenteeism More Costly Than Absenteeism
Pittsburgh Post-Gazette – Quotes Scott Wallace, visiting professor of community and family medicine, about how employees who regularly engage in “presenteeism,” or going to work while ill, is more costly than absenteeism and is detrimental to employees and employers alike. “Unhealthy workers are unproductive workers—and they’re expensive,” says Wallace. “The impact on employees is tremendous when they show up at work sick. The stress makes them sicker, and their performance level at work is in the gutter.”
After Menopause, Vulvovaginal Troubles Are Common
Reuters – Quotes Elisabeth Erekson, assistant professor of obstetrics and gynecology and of The Dartmouth Institute for Health Policy and Clinical Practice, about how after menopause more than half of women have vulvovaginal symptoms and most do not get the standard treatments necessary.
Dartmouth Study: More Babies Receive Intensive Care
Valley News via St. Louis Post-Dispatch – Continued coverage of comments by David Goodman, professor of pediatrics, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about how Dartmouth researchers recently found that NICU admissions increased by 23 percent in just five years; and by 2012, over half of all admissions were for normal birth weight infants or those born after 37 weeks gestation.
At the Hospitals: Dartmouth-Hitchcock Boards of Trustees Elect Chair, New Board Members
Valley News – Jeff Cohen, chair and professor of neurology, and Brian Spence ’96, Thayer ’95, associate professor of anesthesiology, and Timothy Scherer, instructor in medicine, were recently elected as new members of Dartmouth-Hitchcock’s board of trustees.
Safety, Efficacy Trial Begins for Endoscopic Weight-Loss Device
Healio – Quotes Richard Rothstein, the Joseph M. Huber Professor and Chair of Medicine, about the safety and efficacy of the TransPyloric Shuttle—a removable weight-loss device that is inserted endoscopically through the mouth.
Mental Health Apps—They Help but We Don’t Know How Much
The Epoch Times – Quotes Lisa Marsch, associate professor of psychiatry and director of the Center for Technology and Behavioral Health, about how major research institutions that develop carefully tested apps for mental health often don’t have the resources to market the final product or build platforms that can handle millions of users if they do become popular.
FDA Repeatedly Approved Cancer Drug Afinitor Without Proof it Extended Life
Milwaukee Journal Sentinel – Cites research conducted by Lisa Schwartz and Steven Woloshin, both professors of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about the effects of the drug Afinitor. Despite serious side effects, the drug has been OK’d five times in the last six years, including for a common type of advanced breast cancer.